Literature DB >> 4290368

In vitro neoplastic transformation of newborn hamster salivary-gland tissue by oncogenic DNA viruses.

S A Wells, A S Rabson, R A Malmgren, A S Ketchmam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4290368     DOI： 10.1002/1097-0142(196610)19:10<1411::aid-cncr2820191012>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Transformation of hamster embryo fibroblasts by SV40-adeno 7 hybrid virus and the properties of the transformed cells.

Authors:  V Vonka; L Kutinová; H Závadová; D Rezácová
Journal:  Arch Gesamte Virusforsch       Date:  1969

2.  Histopathology of sarcomas induced in hamsters by clones of in-vitro SV40-transformed homologous heart cells. Attempts to correlate morphologic features and degree ofoncogenic potential.

Authors:  G T Diamandopoulos
Journal:  Am J Pathol       Date:  1968-11       Impact factor: 4.307

3.  Induction in hamsters of various carcinomas and sarcomas by in-vitro SV40-transformed homologous embryonic skin and subcutaneous tissue cells. Role of target cells in determining tumor morphology.

Authors:  G T Diamandopoulos; M F Dalton-Tucker
Journal:  Am J Pathol       Date:  1969-07       Impact factor: 4.307

4.  Comparison of the in vitro cytology of hamster embryo cell lines transfored "spontaneously" or by SV40: with contrast of sarcomas induced in the homologous host.

Authors:  G T Diamandopoulos
Journal:  Am J Pathol       Date:  1968-03       Impact factor: 4.307

Review 5.  [Morphology of salivary gland diseases].

Authors:  G Seifert; K Donath
Journal:  Arch Otorhinolaryngol       Date:  1976

6.  In vitro transformation by adenovirus-simiam virus 40 hybrid viruses. IV. Properties of clones isolated from cell lines transformed by adenovirus 2-simiam virus 40 and adenovirus 12-simiam virus 40 transcapsidant hybird viruses.

Authors:  P H Black; L D Berman; C B Dixon
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.